Glenmorgan Investments On Track to Reach $7 Billion in Assets Under Management
6.2.2025 08:00:00 CET | ACCESS Newswire | Press release
Glenmorgan Investments, a leading global investment firm, is excited to announce record capital inflows across both institutional and retail sectors in the first six weeks of 2025.
LONDON, UNITED KINGDOM / ACCESS Newswire / February 6, 2025 / The company is on track to surpass $7 billion in assets under management (AUM) by the time it reports its Q1 2025 results, marking a significant milestone in its ongoing growth and success.
These impressive inflows come as a direct result of the company's continued dedication to innovative investment strategies, which have garnered strong interest from both institutional investors and individual retail clients. Glenmorgan's diverse portfolio and commitment to delivering exceptional returns have been key drivers in attracting new capital during this record-breaking period.
In particular, the company has experienced a significant surge in retail investor participation since the announcement that the highly sought-after Digital Asset Innovation Fund would temporarily reopen to new investors. The move has sparked renewed interest among individual investors eager to gain exposure to the rapidly growing digital asset sector. The fund, which targets emerging technologies and innovative solutions within decentralized finance, has proven to be a standout opportunity in a year marked by technological advancements and a bullish market for digital assets.
"The overwhelming interest from both institutional and retail investors in the early part of 2025 highlights the strength of our investment strategies and the trust investors place in Glenmorgan Investments," said Mr. Robert Cavendish, Head of Fund Management, at Glenmorgan Investments. "We are thrilled to be on track to reach $7 billion in AUM by the end of Q1, and we remain committed to providing our investors with cutting-edge opportunities, such as the reopening of the Digital Asset Innovation Fund, that drive growth and long-term value."
Glenmorgan Investments' ability to attract capital from a broad spectrum of investors further reinforces its position as an industry leader and demonstrates the continued demand for innovative, high-growth investment solutions.
Media Enquiries:
Mrs. Susan Harper
Media and Public Relations Manager
Email: media@glenmorganinvestments.com
Tel: +44(0)20 3355 9612
Web: www.glenmorganinvestments.com
Address: City Reach, 5-6 Greenwich View Place, London E14 9NN, United Kingdom
SOURCE: Glenmorgan Investments Limited
View the original press release on ACCESS Newswire
Glenmorgan Investments Limited
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Bayer to Present How it Rebuilt Global Planning with OMP at Gartner Supply Chain Planning Summit 202617.9.2026 13:52:00 CEST | Press release
ANTWERPEN, BE / ACCESS Newswire / September 17, 2026 / OMP, a leading provider of supply chain planning solutions, invites attendees of the Gartner Supply Chain Planning Summit 2026 in London to its joint session with multinational Bayer. Representatives of the Pharmaceutical division and the global IT department will show what it took to rebuild global planning around faster, higher-quality decisions, how Unison Planning™ supports that at scale, and where AI fits in. Rebuilding planning at Bayer's scale Bayer treated its move to Unison Planning™ as more than a system replacement, rebuilding processes, master data, and ways of working across its global manufacturing and affiliate network. During their Gartner session, Mirja Meyer, Principal Product Manager and Program Lead IT at Bayer, and Karsten Hahm, Program Lead OMP Implementation at Bayer Pharmaceuticals, will cover:What adoption actually tookWhat changed in decision speed and qualityWhere AI fits on the roadmap ahead Sign up for
U.S. Polo Assn. Celebrates New Partnership with the Historic Greenwich Polo Club at the 2026 East Coast Open Presented by Audi17.9.2026 13:00:00 CEST | Press release
WEST PALM BEACH, FL / ACCESS Newswire / September 17, 2026 / U.S. Polo Assn.®, the official sports brand of the United States Polo Association (USPA), celebrated the conclusion of the 2026 East Coast Open Presented by Audi, held August 30 through September 13 at the renowned Greenwich Polo Club in Greenwich, Connecticut, a celebrated polo destination just outside New York City. As the only high-goal tournament on the East Coast during the summer season, the historic championship once again brought together elite international competition for the sport of polo. 2026 East Coast Open Presented by Audi Winners, IGEA, celebrating with tournament trophy. Photo Credit: Greenwich Polo Club The 2026 season also marked a significant milestone as U.S. Polo Assn. served as the Official Apparel Brand Sponsor of Greenwich Polo Club for the first time. The new partnership connected one of the world's most recognized sports brands with one of polo's most iconic venues, further strengthening the brand'
GA-ASI Mojave First UAS To Complete Battlefield Short Field Ops16.9.2026 19:30:00 CEST | Press release
Short Takeoff and Landing Aircraft Validates Austere Field Capabilities SAN DIEGO, CA / ACCESS Newswire / September 16, 2026 / General Atomics Aeronautical Systems (GA-ASI) and Hanwha Aerospace have completed the first-ever flight operations from a simulated battlefield by a medium altitude, long endurance uncrewed aircraft. The partners proved that the Mojave Short Takeoff and Landing aircraft, or Mojave STOL, could land at a tank and artillery live-fire range during simulated combat conditions and then take off again to continue the mission. "This demonstration showcased Mojave's ability to perform tactical missions that are representative of real battlefield requirements and challenges," said GA-ASI CEO Linden Blue. "Whether the user needs contested and austere battlefield operations, ISR, weapons delivery, Air-Launched Effects deployment, troop resupply, counter-UAS, or missions requiring short and unimproved roads for takeoff, our aircraft answer the bell." "This demonstration mar
Freedom Holding Corp. Named General Partner of the Salesforce FIDE World Championship Match 202616.9.2026 16:13:00 CEST | Press release
Partnership builds on Freedom's long-term support for international chess as Geneva prepares to host the historic Gukesh - Sindarov title match NEW YORK CITY, NY / ACCESS Newswire / September 16, 2026 / Freedom Holding Corp. (NASDAQ:FRHC) will serve as General Partner of the Salesforce FIDE World Championship Match 2026, continuing a long-standing partnership with the International Chess Federation (FIDE) spanning elite competition, education and chess development. Freedom's involvement in the 2026 World Championship follows several years of cooperation with FIDE. The company was General Partner of the 2023 World Championship Match in Astana and title sponsor of the 2024 FIDE World Rapid & Blitz Championships in New York, one of FIDE's flagship global events. It has also supported international competitions and initiatives focused on expanding access to chess, developing young talent and strengthening the wider chess ecosystem. Earlier this year, Freedom and FIDE further expanded their
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics16.9.2026 13:00:00 CEST | Press release
Transaction expected to create a Nasdaq-listed, multi-indication clinical-stage company focused on targeting neutrophil extracellular traps (NETs), a driver of disease across critical care, autoimmune disease, transplantation and oncology Union of two companies brings together Santersus' NucleoCapture® technology, designed to physically remove NETs from circulation, with Xenetic's DNase technology, designed to enzymatically degrade NETs in tissue Joint pipeline includes four first-in-class programs, including pivotal-stage programs in sepsis and systemic lupus erythematosus (SLE), both of which have received FDA Breakthrough Device Designation Companies to host Business Update Conference Call and Webcast Today, Wednesday, September 16th at 8:30 AM ET FRAMINGHAM, MA / ACCESS Newswire / September 16, 2026 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic"), a biopharmaceutical company advancing its Deoxyribonuclease ("DNase") technology, and Santersus AG ("Santersus"), a privately held
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom